# A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis Suppurativa

> **NCT01704534** · PHASE2 · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 20 (actual)

## Conditions studied

- Hidradenitis Suppurativa

## Interventions

- **DRUG:** Ustekinumab

## Key facts

- **NCT ID:** NCT01704534
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2014-01
- **Final completion:** 2014-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01704534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01704534, "A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis Suppurativa". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01704534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*